December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
HLA Class I expression in uveal melanoma
Author Affiliations & Notes
  • G Anastassiou
    University of Essen Essen Germany
    Ophthalmology
  • V Rebmann
    Immunology
    University of Essen Essen Germany
  • S Wagner
    Dermatology
    University of Essen Essen Germany
  • H Grosse-Wilde
    Immunology
    University of Essen Essen Germany
  • N Bornfeld
    University of Essen Essen Germany
    Ophthalmology
  • Footnotes
    Commercial Relationships   G. Anastassiou, None; V. Rebmann, None; S. Wagner, None; H. Grosse-Wilde, None; N. Bornfeld, None.
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2209. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      G Anastassiou, V Rebmann, S Wagner, H Grosse-Wilde, N Bornfeld; HLA Class I expression in uveal melanoma . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2209.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose: As the expression of classical and non-classical HLA antigens is crucial for the recognition and elimination of tumor cells by cytotoxic T- and/or NK-cells, we analyzed the HLA-A,B,C and G expression in uveal melanoma of 18 patients. Methods: Tumor specimens and EDTA plasma samples from 18 patients treated by primary enucleation or tumor resection for primary uveal melanoma in the University Eye Clinic of Essen were collected immediate after surgery. After solubilisation of tumor tissue and specific immunoprecipitation of classical HLA-A,B,C and non-classical HLA-G antigens the tumor samples were analyzed by one dimensional isoelectrical focusing (1D-IEF) and Western Blotting. In parallel, patients were typed for HLA-A,B,C class I antigens by PCR-SSP. In addition, HLA-A2 and HLA-G expression was investigated by immunohistochemistry (ICH) in paraffin embedded tumor material of these patients. Results: In 10 out of 18 tumors (56 %) full HLA-A and B antigen expression pattern was detected by 1D-IEF. In 6 tumor tissues (33 %) a HLA class I allele was missing (HLA-A2, A28, A29, B13, B18, B55), in 1 case an haplotypic loss (HLA-A2, B44) and in an other case an allele specific loss combined with haplotypic loss (HLA-A26,32, B41) were observed. HLA-C and HLA-G antigens were detectable in none of the tumor samples by the 1D-IEF. Even in the ICH only 2 out of 18 (11 %) tumors showed an immunoreactivity with the anti-HLA-G monoclonal antibody. ICH analysis for HLA-A2 expression confirmed the results of 1D-IEF. Conclusion: A considerable portion of the uveal melanomas tested showed a loss of classical HLA class I antigens which might enable them to escape from the immunosurveillance of cytotoxic T-cells. However, HLA-C and G antigens were not expressed in uveal melanoma implying a possible susceptibility for NK-cell mediated lysis.

Keywords: 464 melanoma • 435 immunomodulation/immunoregulation • 496 oncology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×